Geneva Capital Management LLC reduced its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 4.5% in the 3rd quarter, Holdings Channel reports. The fund owned 87,823 shares of the biotechnology company’s stock after selling 4,176 shares during the period. Geneva Capital Management LLC’s holdings in Axon Enterprise were worth $37,107,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of AXON. M & L Capital Management Ltd purchased a new position in shares of Axon Enterprise during the 3rd quarter worth $30,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Axon Enterprise during the second quarter worth $31,000. Wealth Enhancement Trust Services Inc. acquired a new stake in shares of Axon Enterprise during the third quarter worth $33,000. Putney Financial Group LLC purchased a new stake in shares of Axon Enterprise in the third quarter valued at $36,000. Finally, Washington Trust Advisors Inc. grew its position in shares of Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after purchasing an additional 65 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms recently commented on AXON. Morgan Stanley upped their target price on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Raymond James Financial set a $675.00 target price on Axon Enterprise in a research report on Thursday, October 15th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. UBS Group raised their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Finally, Piper Sandler restated an “overweight” rating and issued a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a report on Friday, November 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $612.18.
Check Out Our Latest Analysis on Axon Enterprise
Axon Enterprise Stock Performance
NASDAQ:AXON opened at $315.43 on Monday. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The company has a market cap of $25.69 billion, a P/E ratio of 101.10, a P/E/G ratio of 5.99 and a beta of 1.48. Axon Enterprise, Inc has a fifty-two week low of $291.45 and a fifty-two week high of $665.07. The firm’s 50 day moving average is $417.79 and its two-hundred day moving average is $467.68.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The company had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter last year, the business earned $1.17 EPS. The firm’s revenue for the quarter was up 27.8% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc will post 2.10 EPS for the current year.
Insider Transactions at Axon Enterprise
In related news, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the transaction, the president owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares in the company, valued at $1,587,036,927.88. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
See Also
- Five stocks we like better than Axon Enterprise
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
